We_PRP previously_RB identified_VBD a_DT Fas_NN ligand_NN regulatory_JJ element_NN FLRE_NN in_IN the_DT Fas_NN ligand_NN fasL_NN promoter_NN that_IN binds_VBZ Egr_NN family_NN proteins_NNS and_CC demonstrated_VBD that_IN Egr-3_NN PILOT_NN but_CC not_RB Egr-1_NN NGFI-A_NN ,_, Krox-24_NN ,_, Tis-8_NN ,_, and_CC Zif-268_NN induces_VBZ transcription_NN of_IN fasL_NN ._.
The_DT induction_NN of_IN the_DT AP-1_NN transcription_NN factor_NN has_VBZ been_VBN ascribed_VBN to_TO the_DT early_JJ events_NNS leading_VBG to_TO T_NN cell_NN differentiation_NN and_CC activation_NN ._.
The_DT transcription_NN factor_NN E2F_NN activates_VBZ the_DT expression_NN of_IN multiple_JJ genes_NNS involved_VBN in_IN cell_NN proliferation_NN ,_, such_JJ as_IN c-myc_NN and_CC the_DT dihydrofolate_JJ reductase_NN gene_NN ._.
In_IN this_DT report_NN ,_, we_PRP address_VBP the_DT possibility_NN of_IN rapid_JJ mutational_JJ analysis_NN of_IN the_DT androgen_NN receptor_NN gene_NN for_IN initial_JJ diagnosis_NN ,_, genetic_JJ counseling_NN ,_, and_CC molecular_JJ subclassification_NN of_IN affected_VBN patients_NNS and_CC families_NNS ._.
To_TO evaluate_VB the_DT role_NN in_IN myelopoiesis_NN ,_, transgenic_JJ mice_NNS expressing_VBG were_VBD engineered_VBN ._.
Two_CD unrearranged_JJ TcR_NN delta_NN transcripts_NNS had_VBD a_DT size_NN similar_JJ to_TO that_DT of_IN the_DT functional_JJ TcR_NN delta_NN mRNA_NN 2.3_CD and_CC 1.3_CD kb_NN found_VBN in_IN TcR_NN T_NN lymphocytes_NNS ._.
These_DT results_NNS indicate_VBP that_IN ,_, among_IN HIV1_NN gene_NN products_NNS ,_, the_DT Tat_NN protein_NN appears_VBZ to_TO trigger_VB monocytic_JJ differentiation_NN ,_, and_CC suggests_VBZ that_IN this_DT viral_JJ protein_NN directs_VBZ progenitors_NNS of_IN the_DT lineage_NN towards_IN a_DT differentiation_NN stage_NN in_IN which_WDT production_NN of_IN viral_JJ antigens_NNS and_CC virions_NNS might_MD be_VB more_RBR efficient_JJ ._.
Soluble_JJ factors_NNS secreted_VBN by_IN activated_VBN T-lymphocytes_NNS modulate_VBP the_DT transcription_NN of_IN the_DT immunosuppressive_JJ cytokine_NN TGF-beta_NN 2_CD in_IN glial_JJ cells_NNS ._.
When_WRB the_DT calcium_NN ionophore_NN was_VBD used_VBN in_IN conjunction_NN with_IN TPA_NN ,_, a_DT PKC_NN activator_NN ,_, the_DT Zp_NN induction_NN was_VBD synergistically_RB enhanced_VBN ._.
Furthermore_RB ,_, we_PRP evaluated_VBD the_DT mineralocorticoid_NN receptor_NN MR_NN count_NN in_IN mononuclear_JJ leukocytes_NNS in_IN the_DT 2_CD groups_NNS ._.
Except_IN for_IN the_DT conserved_VBN zinc-finger_NN domains_NNS ,_, the_DT amino_NN acid_NN sequences_NNS of_IN the_DT three_CD proteins_NNS are_VBP distinct_JJ ._.
Various_JJ cellular_JJ stimuli_NNS relieve_VBP this_DT inhibition_NN by_IN mechanisms_NNS largely_RB unknown_JJ ,_, leading_VBG to_TO NF-kappa_NN B_NN nuclear_JJ localization_NN and_CC transactivation_NN of_IN target_NN genes_NNS ._.
Expression_NN of_IN full-length_JJ and_CC mutant_JJ cDNA_NN clones_NNS in_IN bacteria_NNS reveal_VBP that_IN the_DT single_JJ HMG_NN motif_NN ,_, which_WDT is_VBZ predicted_VBN to_TO contain_VB two_CD extended_VBN alpha-helical_JJ segments_NNS ,_, is_VBZ sufficient_JJ to_TO direct_VB the_DT sequence-specific_JJ binding_NN of_IN TCF-1_NN alpha_NN to_TO DNA_NN ._.
To_TO delineate_VB the_DT effects_NNS of_IN these_DT motifs_NNS on_IN the_DT replicative_JJ capacity_NN of_IN HIV_NN and_CC to_TO explore_VB the_DT possibility_NN of_IN extending_VBG the_DT virus_NN host_NN range_NN ,_, known_VBN heterologous_JJ were_VBD inserted_VBN into_IN the_DT HIV-1_NN LTR_NN in_IN place_NN of_IN the_DT NF-kappa_NN B_NN and_CC Sp1_NN binding_NN sites_NNS ._.
The_DT activity_NN of_IN the_DT promoter_NN regulating_VBG the_DT synthesis_NN of_IN the_DT p105_NN precursor_NN of_IN the_DT NF-kappa_NN B_NN p50_NN subunit_NN was_VBD enhanced_VBN in_IN these_DT cells_NNS ._.
Pentoxifylline_NN ,_, a_DT trisubstituted_JJ xanthine_NN derivative_NN ,_, has_VBZ been_VBN used_VBN to_TO decrease_VB blood_NN viscosity_NN and_CC is_VBZ reasonably_RB well_RB tolerated_VBN by_IN most_JJS recipients_NNS of_IN the_DT drug_NN ._.
Two_CD proteins_NNS binding_VBG the_DT kappa_NN B_NN sequence_NN ,_, NF-kappa_NN B_NN and_CC KBF1_NN ,_, are_VBP constitutively_RB expressed_VBN in_IN IARC_NN 301_CD nuclei_NNS and_CC induced_VBN by_IN PMA_NN and_CC PHA_NN in_IN Jurkat_NN ._.
TCF-1_NN belongs_VBZ to_TO the_DT family_NN of_IN transcription-regulating_JJ proteins_NNS which_WDT share_VBP a_DT region_NN of_IN homology_NN termed_VBN the_DT HMG-box_NN ._.
Thus_RB the_DT inhibitory_JJ effect_NN of_IN insulin_NN on_IN the_DT GR_NN binding_NN power_NN is_VBZ both_CC dose-_NN and_CC time-dependent_JJ ,_, which_WDT strongly_RB suggests_VBZ that_IN GR_NN is_VBZ tonically_RB controlled_VBN by_IN insulin_NN concentration_NN change_NN under_IN physiological_JJ conditions_NNS ._.
When_WRB stably_RB introduced_VBN into_IN primary_JJ erythroblasts_NNS or_CC conditionally_RB transformed_VBN erythroid_JJ progenitors_NNS cells_NNS ,_, exogenous_JJ promoted_VBD proliferation_NN and_CC inhibited_VBD terminal_JJ differentiation_NN in_IN an_DT estrogen-dependent_JJ manner_NN ._.
The_DT impaired_JJ transcription_NN factor_NN AP-1_NN DNA_NN binding_NN activity_NN in_IN lymphocytes_NNS derived_VBN from_IN subjects_NNS with_IN some_DT symptoms_NNS of_IN premature_JJ aging_NN ._.
We_PRP have_VBP found_VBN that_IN purified_VBN human_JJ peripheral-blood_JJ granulocytes_NNS express_VBP constitutively_RB significant_JJ levels_NNS of_IN proto-oncogenes_NNS c-jun_NN ,_, jun_NN B_NN and_CC jun_NN D_NN mRNA_NN ._.
Likewise_RB ,_, enhanced_VBN expression_NN of_IN exogenous_JJ in_IN erythroblasts_NNS rendered_VBD them_PRP susceptible_JJ to_TO modulation_NN of_IN differentiation_NN by_IN T3_NN ,_, suggesting_VBG a_DT similar_JJ function_NN of_IN both_DT receptors_NNS ._.
analyses_NNS show_VBP that_IN several_JJ Oct2_NN isoforms_NNS can_MD stimulate_VB from_IN a_DT remote_JJ position_NN but_CC that_IN this_DT stimulation_NN is_VBZ restricted_JJ to_TO B_NN cells_NNS ._.
We_PRP have_VBP used_VBN a_DT 32P-labeled_JJ oligonucleotide_NN derived_VBN from_IN human_JJ immunodeficiency_NN virus_NN HIV-1_NN long_JJ terminal_JJ repeat_NN ,_, which_WDT contains_VBZ a_DT tandem_JJ repeat_NN of_IN the_DT NF_NN kappa_NN B_NN binding_NN sequence_NN ,_, as_IN a_DT probe_NN in_IN a_DT gel_NN retardation_NN assay_NN to_TO study_VB this_DT transcription_NN factor_NN ._.